杀人的合同:GNAS突变
Pratima Raut1, Poompozhil Mathivanan1, Surinder K Batra2,3
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198-5870, USA.
Molecular cancer
|March 6, 2025
概括
激活GNAS外基因中的突变,称为gsp瘤基因,驱动许多癌症. 针对这些GNAS突变,为瘤提供了有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 在GNAS外体中激活突变,称为gsp瘤基因,是 heterotrimeric G 蛋白驱动瘤发生的最常见突变.
- 像GNAS R201和Q227这样的特定突变在各种瘤中普遍存在,包括垂体,甲状腺和结直肠癌.
研究的目的:
- 审查gsp瘤基因的重要性及其在癌症发展中的作用.
- 突出最近对瘤性GNAS的机制性见解.
- 探索针对GNAS突变的治疗策略.
主要方法:
- 关于瘤性GNAS的最近研究的文献综述.
- 对各种癌症中GNAS突变流行率的分析.
- 探索治疗方法,包括疫苗治疗和小分子抑制剂.
主要成果:
- 瘤性GNAS突变对于瘤的形成,进展和维持至关重要.
- Gsα具有作为疫苗治疗中的新抗原的潜力.
- 基因基因特异和小分子抑制剂显示出治疗前景.
结论:
- 向瘤性GNAS突变是一种可行的治疗策略,用于GNAS驱动的癌症.
- 对新型治疗方式和以患者为中心的研究进行进一步的研究是有必要的.
- 了解GNAS驱动的瘤的基因组和生物格局对于有效的治疗至关重要.
相关概念视频
01:08Nucleotide Excision Repair
Overview
01:39Mutations
Overview
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...